Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
3.040
+0.190 (6.67%)
At close: Aug 13, 2025, 4:00 PM
3.000
-0.040 (-1.32%)
Pre-market: Aug 14, 2025, 9:08 AM EDT
Evaxion Market Cap
Evaxion has a market cap or net worth of $19.20 million as of August 14, 2025. Its market cap has increased by 17.31% in one year.
Market Cap
19.20M
Enterprise Value
1.36M
1-Year Change
17.31%
Ranking
Category
Stock Price
$3.04
Market Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $19.20M, a decrease of -90.00%. That is a compound annual growth rate of -39.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 19.20M | 287.21% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |